We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says Firm's Surgical Drapes Exceed Bioburden Levels
FDA Says Firm's Surgical Drapes Exceed Bioburden Levels
April 5, 2007
Medical Concepts Development (MCD) failed to take corrective action to address bioburden levels exceeding action/alert thresholds on its surgical drapes, according to a recent FDA warning letter.